AUTHORITATIVE LEGAL GUIDES

Eye doctor with female patient during an examination in modern clinic used in

Trulicity and NAION Update: An Essential Patient Update

Timothy Miles April 16, 2026 No Comments

Introduction to the Trulicity and NAION Update Welcome to this authoritative Trulicity and NAION Update. Recent studies indicate a potential link between GLP-1 receptor agonists, including Trulicity (dulaglutide), and an increased risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a serious “eye stroke” causing sudden, permanent vision loss. While primarily associated with semaglutide, studies suggest a class-wide risk. Key Updates

Saxenda and NAION Update: What You Need to Know

Timothy Miles April 15, 2026 No Comments

Introduction to Saxenda and NAION Update Welcome to this authoritative Saxenda and NAION Update. As of April 2026, Saxenda (liraglutide) and other GLP-1 agonists are heavily involved in litigation regarding Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a serious, often permanent, vision loss condition. Federal multidistrict litigation (MDL 3163) was established in late 2025 to consolidate lawsuits alleging that manufacturer Novo

External eye anatomy infographic. Vector art illustration

Wegovy and NAION Update: The Eye-Opening Side Effect

Timothy Miles April 15, 2026 No Comments

Introduction to Wegovy and NAION Update: The Eye-Opening Side Effect Welcome to this authoritative Wegovy and NAION update. Wegovy (semaglutide) has become a cornerstone medication in modern  weight management. It is clinically validated, widely prescribed, and increasingly normalized as a long-term treatment for chronic obesity. That broader adoption is also changing the risk conversation. As use expands, so does real-world

eye exam two females USED IN Zepbound Eye Problems, Zepbound and Eye Floaters Update, Zepbound and Eye Floaters, Zepbound Eye Stroke, Zepbound and NAION Update, Zepbound and NAION, Zepbound Vision Loss Lawsuit, Zepbound Vision Loss Lawyer, Zepbound Vision Problems, Zepbound vision side effects, Zepbound and vision loss, Zepbound Eye Problems, Zepbound vision problems, Zepbound vision side effects, Zepbound and Blurry Vision, Zepbound eye pain, Zepbound Eye Side Effects, Eligible for a Zepbound Vision Loss Lawsuit, qualify for a Zepbound vision loss lawsuit, Zepbound and Eye eye problems

Zepbound and NAION Update: A Vitally Important Patient Guide

Timothy Miles April 15, 2026 No Comments

Introduction to Zepbound and NAION Update Welcome to this authoritative Zepbound and NAION Update. Zepbound (tirzepatide) is a highly effective medication for chronic weight management, and its rapid adoption reflects a clear reality: obesity is a serious, progressive disease that requires proactive, long-term care. At the same time, patients deserve precise, practical guidance when new safety concerns enter the public

u[ close pircture of beautiful bllue eye in Zepbound and NAION Update

Mounjaro and NAION Update: Demystifying the Latest Risk

Timothy Miles April 15, 2026 No Comments

Introduction to the Mounjaro and NAION Update Welcome to this authoritative Mounjaro and NAION Update.  Interest in GLP-1 based therapies has expanded rapidly, and so has scrutiny of their safety profile. Mounjaro (Tirzepatide) a dual GIP and GLP-1 receptor agonist indicated for type 2 diabetes and used off label in some settings for weight management, is now part of a

young woment getting eye exam used in Wegovy and NAION Update

Waking Up with Blindness: The Link Between Mounjaro and NAION Optic Nerve Damage

Timothy Miles April 14, 2026 No Comments

Introduction to Waking Up with Blindness: The Link Between Mounjaro and NAION Optic Nerve Damage Welcome to this authoritative guide on Mounjaro and NAION.  Non-arteritic anterior ischemic optic neuropathy (NAION) is an acute ischemic injury to the anterior portion of the optic nerve (the optic nerve head). It is considered “non-arteritic” to distinguish it from arteritic ischemic optic neuropathy due to

TIMOTHY L. MILES | FREE CASE EVALUATION

TAKE ACTION: CALL TODAY

"It will be the only call you need to make."